NEW YORK, Nov. 06, 2015 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Oregon on behalf of all persons or entities that purchased the securities of GNC Holdings, Inc. (NYSE:GNC) (“GNC” or the “Company”) during the period May 2, 2013 and October 22, 2015, inclusive (the “Class Period”).
Shareholders of who incurred losses on shares on purchased within the Class Period are urged to contact the firm immediately at firstname.lastname@example.org or (800) 575-0735 or (212) 545-4774.
If you purchased the shares of GNC Holdings, Inc. during the period May 2, 2013 and October 22, 2015, inclusive, you may, no later than December 28, 2015 request that the Court appoint you lead plaintiff of the proposed class.
The filed complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that GNC unlawfully sold thousands of units of products in Oregon that contained picamilon or BMPEA.
Following the October 22, 2015 lawsuit filed by the Attorney General of Oregon claiming that the Company sold nutritional and dietary supplements containing the illegal ingredients picamilon and BMPEA, the value of GNC shares declined significantly, closing at $34.50, down $5.73 (14%), a market capitalization loss of $475 million.
Wolf Haldenstein has extensive experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas; and offices in New York, Chicago and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly recognized by the courts, which have appointed it to major positions in complex securities multi-district and consolidated litigation.
If you wish to discuss this action or have any questions regarding your rights and interests in this case, please immediately contact Wolf Haldenstein Adler Freeman & Herz LLP by telephone at (800) 575-0735, via e-mail at email@example.com, or visit our website at www.whafh.com. All e-mail correspondence should make reference to the “GNC Holdings Investigation.”
Attorney Advertising. Prior results do not guarantee or predict a similar outcome.
Contact: Wolf Haldenstein Adler Freeman & Herz LLP Patrick Donovan, Esq. Gregory Stone, Director of Case and Financial Analysis Email: firstname.lastname@example.org, email@example.com or firstname.lastname@example.org Tel: (800) 575-0735 or (212) 545-4774
Source:Wolf Haldenstein Adler Freeman & Herz LLP